Potential of immobilized artificial membrane chromatography for lipophilicity determination of arylpropionic acid non-steroidal anti-inflammatory drugs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 33, Issue 2, 2003, Pages 137-144

  Pehourcq, Fabienne ^a   Jarry, Christian ^b   Bannwarth, Bernard ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Laboratoire de Pharmacochimie   (France)

Author keywords

Arylpropionic acid; Immobilized artificial membrane chromatography; Lipophilicity; Partition coefficient

Indexed keywords

ALMINOPROFEN; ARYLPROPIONIC ACID DERIVATIVE; CARPROFEN; CHEMICAL COMPOUND; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OCTADECYLSILANE; OCTANOL; PIRPROFEN; SILANE DERIVATIVE; SUPROFEN; TIAPROFENIC ACID; UNCLASSIFIED DRUG; WATER;

ARTICLE; ARTIFICIAL MEMBRANE; CHEMICAL PARAMETERS; CORRELATION ANALYSIS; DRUG METABOLISM; IONIZATION; LIPOPHILICITY; LIQUID CHROMATOGRAPHY; PARTITION COEFFICIENT; PH MEASUREMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0042827308     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00257-7     Document Type: Article

References (30)

1. Hansch C., Fujita T. J. Am. Chem. Soc. 86:1964;1616-1626.
2. Leo J.A., Hansch C., Elkins D. Chem. Rev. 71:1971;525-554.
3. Braumann T. J. Chromatogr. 373:1986;191-225.
4. Lambert W.J. J. Chromatogr. A. 656:1993;469-484.
5. Gil-Agusti M., Alvarez-Coque M.C., Esteve-Romero J. Anal. Chim. Acta. 421:2000;45-55.
6. Harnisch M., Mockel H.J., Schulze G.J. J. Chromatogr. 282:1983;315-332.
7. Kaliszan R., Kaliszan A., Wainer I.W. J. Pharm. Biomed. Anal. 11:1993;505-511.
8. Turhhofer H., Schnabel J., Betz M., Lipka G., Pidgeon C., Hauser H. Biochim. Biophys. Acta. 1064:1991;275-286.
9. Ong S., Liu H., Pidgeon C. J. Chromatogr. A. 728:1996;113-128.
10. Pidgeon C., Ong S., Liu H., Qui X., Pidgeon M., Dantzig A.H., Munroe J., Hornback W.J., Kasher J.S., Glunz L., Szczerba T. J. Med. Chem. 38:1995;590-594.
11. Barbato F., La Rotonda M., Quaglia F. J. Pharm. Sci. 86:1997;225-229.
12. Caldwell W., Masucci J.A., Evangelisto M., White R. J. Chromatogr. A. 800:1998;161-169.
13. Netter P., Bannwarth B., Royer-Morrot M. Clin. Pharmacokinet. 17:1989;145-162.
14. Péhourcq F., Matoga M., Jarry C., Bannwarth B. J. Liq. Chrom. Rel. Technol. 24:2001;2177-2186.
15. Bechalany A., Röthlisberger T., El Tayar N., Testa B. J. Chromatogr. 473:1989;115-124.
16. Lepont C., Poole C.F. J. Chromatogr. A. 946:2002;107-124.
17. Kugel C., Heintzelmann B., Wagner J. J. Chromatogr. A. 667:1994;29-35.
18. Escuder-Gilabert L., Sagrado S., Villanueva-Camanas R.M., Medina-Hernàndez M.J. J. Chromatogr. B. 740:2000;59-70.
19. Kaliszan R., Nasal A., Bucinski A. Eur. J. Med. Chem. 29:1994;163-170.
20. Ong S., Lui H., Qui X., Bhat G., Pigeon C. Anal. Chem. 15:1995;755-762.
21. Stewart B.H., Chung F.Y., Tait B., John C., Chan O.H. Pharm. Res. 15:1998;1401-1406.
22. Kepczynska E., Bojarski J., Haber P., Kaliszan R. Biomed. Chromatogr. 14:2000;256-260.
23. Taillardat-Bertschinger A., Galland A., Carrupt P.A., Testa B. J. Chromatogr.A. 953:2002;39-53.
24. Nasal A., Sznitowska M., Bucinski A., Kaliszan R. J. Chromatogr. A. 692:1995;83-89.
25. Yang C.Y., Cai S.J., Liu H., Pidgeon C. Adv. Drug Deliver. Rev. 23:1996;229-256.
26. Caruso I., Corvi G., Fuccella L., Moro E., Sacchetti G., Tamassia V. Int. J. Clin. Pharmacol. 15:1977;411-416.
27. Ray J., Wade D., Graham G., Ray R. J. Clin. Pharmacol. 19:1979;635-643.
28. Jack D.B. Handbook of Clinical Pharmacokinetic Data. 1992;Macmillan Publishers Ltd.
29. Matoga M., Péhourcq F., Lagrange F., Tramu G., Bannwarth B. Arznei.-Forsch.: Drug Res. 49:1999;477-482.
30. Kaliszan R., Nasal A., Bucinski A. Eur. J. Med. Chem. 29:1994;163-170.